Fumitaka Kikkawa
- Molecular Biology top 1%
- Reproductive Medicine top 0.05%
- Oncology top 0.5%
- Obstetrics and Gynecology top 0.1%
- Radiology, Nuclear Medicine and Imaging top 0.5%
- Co-authors
- Hiroaki KajiyamaKiyosumi ShibataKazuhiko InoAkihiro NawaShigehiko MizutaniHiromasa TanakaMasaru HoriKae Nakamura
- Topics
- Ovarian cancer diagnosis and treatment (126 papers)Endometrial and Cervical Cancer Treatments (58 papers)Endometriosis Research and Treatment (51 papers)
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Fumitaka Kikkawa
546 papers receiving 15.1k citations
Hit Papers
Peers
Comparison fields: 5 of 165
- Molecular Biology 4.5k
- Reproductive Medicine 4.1k
- Oncology 3.1k
- Obstetrics and Gynecology 2.4k
- Radiology, Nuclear Medicine and Imaging 2.4k
Countries citing papers authored by Fumitaka Kikkawa
This map shows the geographic impact of Fumitaka Kikkawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumitaka Kikkawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumitaka Kikkawa more than expected).
Fields of papers citing papers by Fumitaka Kikkawa
This network shows the impact of papers produced by Fumitaka Kikkawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumitaka Kikkawa. The network helps show where Fumitaka Kikkawa may publish in the future.
Co-authorship network of co-authors of Fumitaka Kikkawa
This figure shows the co-authorship network connecting the top 25 collaborators of Fumitaka Kikkawa. A scholar is included among the top collaborators of Fumitaka Kikkawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumitaka Kikkawa. Fumitaka Kikkawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 9 | |
| 5 | 6 | |
| 6 | 17 | |
| 7 | 24 | |
| 8 | 18 | |
| 9 | 36 | |
| 10 | 11 | |
| 11 | 2 | |
| 12 | 186 | |
| 13 | 28 | |
| 14 | 59 | |
| 15 | 44 | |
| 16 | 12 | |
| 17 | A newly synthesized bifunctional inhibitor, CKA1083, enhances adriamycin activity against human ovarian carcinoma cells. | 2 |
| 18 | Aminopeptidase P in human placenta and pregnancy serum | 2 |
| 19 | A newly synthesized bifunctional inhibitor, W-77, enhances adriamycin activity against human ovarian carcinoma cells. | 10 |
| 20 | Potentiating effect of amphotericin B on five platinum anticancer drugs in human cis-diamminedichloroplatinum (II) sensitive and resistant ovarian carcinoma cells. | 12 |
About Fumitaka Kikkawa
Fumitaka Kikkawa is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Public Health, Environmental and Occupational Health, having authored 552 papers that have together received 15.4k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (126 papers), Endometrial and Cervical Cancer Treatments (58 papers) and Endometriosis Research and Treatment (51 papers). The work is most often cited by research in Reproductive Medicine (4.1k citations), Obstetrics and Gynecology (2.4k citations) and Biological Psychiatry (439 citations). Fumitaka Kikkawa has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Hiroaki Kajiyama, Kiyosumi Shibata, Kazuhiko Ino, Akihiro Nawa, Shigehiko Mizutani, Hiromasa Tanaka, Masaru Hori, Kae Nakamura, Akira Iwase and Masaaki Mizuno. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Applied Physics Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.